KOPRAN
Back to Balance Sheet
|
KOPRAN Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹19 Cr | ₹17 Cr | ₹18 Cr | ₹20 Cr | ₹41 Cr |
What is the latest Contingent Liabilities ratio of KOPRAN ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹19 Cr |
| Mar2025 | ₹17 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹20 Cr |
| Mar2022 | ₹41 Cr |
How is Contingent Liabilities of KOPRAN Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹19 Cr | 10.64 | |
| Mar2025 | ₹17 Cr | -5.24 | |
| Mar2024 | ₹18 Cr | -9.05 | |
| Mar2023 | ₹20 Cr | -51.22 | |
| Mar2022 | ₹41 Cr | - | |
Compare Contingent Liabilities of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹1,155.8 Cr | -3.9% | -17.6% | 48.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -3.9% |
-17.6% |
48.1% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses